Today’s Research Reports on Trending Tickers: MannKind Corporation and Pacific Biosciences of California
NEW YORK, NY / ACCESSWIRE / January 26, 2018 / Strong earnings from major companies such as 3M and Boeing helped lift the Dow and S&P 500 to new record highs on Thursday. The Dow Jones Industrial Average jumped 0.54 percent to close at 26,392.79, while the S&P 500 Index rose 0.06 percent to close at 2,839.25. The Nasdaq Composite Index hit a high of 7,458.53 in early trading before settling to close at 7,411.16, down 0.05 percent.
"The numbers companies are releasing, along with the upbeat views from executives, is helping analysts lift their estimates and that's helping stocks advance," said Mark Luschini, chief investment strategist at Janney, according to CNBC. "You [also] have strong U.S. and overseas economic growth, and that is supportive for stocks."
RDI Initiates Coverage on:
MannKind Corporation
https://rdinvesting.com/news/?ticker=MNKD
Pacific Biosciences of California
https://rdinvesting.com/news/?ticker=PACB
MannKind's stock jumped 41.26% Thursday, to close the day at $3.80. The stock recorded a trading volume of 38,692,780 shares, which was above its three months average volume of 3,164,377 shares. In the last year, MannKind's shares have traded in a range of 0.67 - 6.96. The share price has gained 467.16% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.62 is greater than its 200-day moving average of $2.53. Shares of MannKind have gained roughly 57.68 percent in the past month and are up 63.79 percent year-to-date.
Access RDI's MannKind Corporation Research Report at:
https://rdinvesting.com/news/?ticker=MNKD
On Thursday, shares in Pacific Biosciences of California recorded a trading volume of 4,693,220 shares, which was above the three months average volume of 1,029,800 shares. The stock ended the day 19.63% higher at 3.23. The share price has gained 28.69% from its 52 week low with a 52 week trading range of 2.51 - 5.74. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.72 is below its 200-day moving average of $3.77. Shares of Pacific Biosciences of California have gained roughly 20.97 percent in the past month and are up 22.35 percent year-to-date.
Access RDI's Pacific Biosciences of California Research Report at:
https://rdinvesting.com/news/?ticker=PACB
Our Actionable Research on MannKind Corporation (NASDAQ:MNKD) and Pacific Biosciences of California (NASDAQ:PACB) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
